Enanta Pharmaceuticals (ENTA) Other Gross PP&E Adjustments (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Other Gross PP&E Adjustments of -$37.3 million for Q1 2026, down 305.88% year-on-year from $18.1 million in Q1 2025, and up 1.3% on a QoQ basis from -$37.8 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Other Gross PP&E Adjustments data on file, last reported at -$37.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 305.88% year-over-year to -$37.3 million; the trailing twelve-month figure through Mar 2026 stood at -$37.3 million (down 305.88% YoY), and the FY2025 full-year result was $20.3 million, up 702.26% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$37.3 million, up from -$37.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $20.3 million in Q3 2025 and bottomed at -$37.8 million in Q4 2025.
- The 5-year median for Other Gross PP&E Adjustments is -$17.8 million (2022), against an average of -$10.6 million.
- Peak annual rise in Other Gross PP&E Adjustments reached 702.26% in 2025, while the deepest fall reached 330.29% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$23.5 million in 2022, then climbed by 9.33% to -$21.3 million in 2023, then jumped by 176.98% to $16.4 million in 2024, then sank by 330.29% to -$37.8 million in 2025, then grew by 1.3% to -$37.3 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$37.3 million (Q1 2026), -$37.8 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -37.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.35 Mn |
| Mar 31, 2026 | -37.35 Mn |
| Dec 31, 2025 | -37.84 Mn |
| Dec 31, 2025 | -37.84 Mn |
| Sep 30, 2025 | 20.27 Mn |
| Sep 30, 2025 | 20.27 Mn |
| Jun 30, 2025 | 19.58 Mn |
| Jun 30, 2025 | 19.58 Mn |
| Mar 31, 2025 | 18.14 Mn |
| Mar 31, 2025 | 18.14 Mn |
| Dec 31, 2024 | 16.43 Mn |
| Dec 31, 2024 | 16.43 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Mar 31, 2024 | -36.05 Mn |
| Mar 31, 2024 | -36.05 Mn |
| Dec 31, 2023 | -21.34 Mn |
| Dec 31, 2023 | -21.34 Mn |
| Sep 30, 2023 | -4.10 Mn |
| Sep 30, 2023 | -4.10 Mn |
| Jun 30, 2023 | -23.97 Mn |
| Jun 30, 2023 | -23.97 Mn |
| Mar 31, 2023 | -26.19 Mn |
| Mar 31, 2023 | -26.19 Mn |
| Dec 31, 2022 | -23.54 Mn |
| Dec 31, 2022 | -23.54 Mn |
| Sep 30, 2022 | -10.53 Mn |
| Sep 30, 2022 | -10.53 Mn |
| Jun 30, 2022 | -24.94 Mn |
| Jun 30, 2022 | -24.94 Mn |
| Mar 31, 2022 | -17.85 Mn |
| Mar 31, 2022 | -17.85 Mn |
| Dec 31, 2021 | -19.40 Mn |
| Dec 31, 2021 | -19.40 Mn |
| Sep 30, 2021 | 8.32 Mn |
| Sep 30, 2021 | 8.32 Mn |
| Jun 30, 2021 | -6.61 Mn |
| Jun 30, 2021 | -6.61 Mn |
| Mar 31, 2021 | -7.66 Mn |
| Mar 31, 2021 | -7.66 Mn |
| Dec 31, 2020 | -8.28 Mn |
| Dec 31, 2020 | -8.28 Mn |
| Sep 30, 2020 | 6.18 Mn |
| Sep 30, 2020 | 6.18 Mn |
| Jun 30, 2020 | -8.15 Mn |
| Jun 30, 2020 | -8.15 Mn |
| Mar 31, 2020 | -8.34 Mn |
| Mar 31, 2020 | -8.34 Mn |
| Dec 31, 2019 | -8.68 Mn |
| Dec 31, 2019 | -8.68 Mn |
| Sep 30, 2019 | 13.21 Mn |
| Sep 30, 2019 | 13.21 Mn |
| Jun 30, 2019 | -962,000.00 |
| Jun 30, 2019 | -962,000.00 |
| Mar 31, 2019 | -742,000.00 |
| Mar 31, 2019 | -742,000.00 |
| Dec 31, 2018 | -696,000.00 |
| Dec 31, 2018 | -696,000.00 |
| Sep 30, 2018 | 10.09 Mn |
| Sep 30, 2018 | 10.09 Mn |
| Jun 30, 2018 | -773,000.00 |
| Jun 30, 2018 | -773,000.00 |
| Mar 31, 2018 | -748,000.00 |
| Mar 31, 2018 | -748,000.00 |
| Dec 31, 2017 | -523,000.00 |
| Dec 31, 2017 | -523,000.00 |
| Sep 30, 2017 | 7.20 Mn |
| Sep 30, 2017 | 7.20 Mn |
| Jun 30, 2017 | -639,000.00 |
| Jun 30, 2017 | -639,000.00 |
| Mar 31, 2017 | -463,000.00 |
| Mar 31, 2017 | -463,000.00 |
| Dec 31, 2016 | -350,000.00 |
| Dec 31, 2016 | -350,000.00 |
| Sep 30, 2016 | 8.18 Mn |
| Sep 30, 2016 | 8.18 Mn |
| Sep 30, 2015 | 8.03 Mn |
| Sep 30, 2015 | 8.03 Mn |
| Jun 30, 2015 | -372,000.00 |
| Jun 30, 2015 | -372,000.00 |
| Mar 31, 2015 | -328,000.00 |
| Mar 31, 2015 | -328,000.00 |
| Dec 31, 2014 | -228,000.00 |
| Dec 31, 2014 | -228,000.00 |
| Sep 30, 2014 | 5.50 Mn |
| Sep 30, 2014 | 5.50 Mn |
| Jun 30, 2014 | -336,000.00 |
| Jun 30, 2014 | -336,000.00 |
| Mar 31, 2014 | -249,000.00 |
| Mar 31, 2014 | -249,000.00 |
| Dec 31, 2013 | -351,000.00 |
| Dec 31, 2013 | -351,000.00 |
| Sep 30, 2013 | 5.08 Mn |
| Sep 30, 2013 | 5.08 Mn |
| Jun 30, 2013 | -370,000.00 |
| Jun 30, 2013 | -370,000.00 |
| Mar 31, 2013 | -629,000.00 |
| Mar 31, 2013 | -629,000.00 |
| Sep 30, 2012 | 4.43 Mn |
| Sep 30, 2012 | 4.43 Mn |